Reprint

Molecular Biomarkers In Cardiology

Edited by
April 2021
276 pages
  • ISBN978-3-0365-0840-5 (Hardback)
  • ISBN978-3-0365-0841-2 (PDF)

This book is a reprint of the Special Issue Molecular Biomarkers In Cardiology that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary
ear Colleagues, The approach to diseases is facing novel frontiers: targeting gene and improving person-centered medicine able to easily and specifically detect early stages of pathologies. The present book includes the most futuristic approaches to the identification of cardiac diseases by means of the most recent discoveries in molecular and genetic diagnosis. The articles will give you the opportunity to think of cardiac diseases as adverse conditions which can be more easily detected by means of technologies and the research spirit of us, physicians dedicated to humans’ care. Please enjoy this reading.
Format
  • Hardback
License
© by the authors
Keywords
coronary artery disease; differentially expressed genes; hub genes; protein-protein interaction network; pathway enrichment analyses; cardiovascular risk factors; genetic association; inflammation; interleukin 20; polymorphisms; subclinical atherosclerosis; acute coronary syndrome; P-selectin; genetics; polymorphisms; susceptibility; obesity; adipokines; biomolecules; biomarkers; leptin; resistin; visfatin; sarcomere; dilated cardiomyopathy; left ventricle dysfunction; actin; myosin; troponin; tropomyosin; endothelial dysfunction; L-Arg/ADMA; PFO; MTHFR; cryptogenic stroke; multimarker approach; adverse event; risk prediction; canonical discriminant analysis; C-statistics; coronary artery disease; galectin-3; biomarker; diagnostic; prognostic; early stage; heart disease; animal model; coronary artery disease; biomarkers; noncoding RNA; microRNA; genetics; single nucleotide polymorphism; acute coronary syndrome; biophysical markers; cardiac remodeling post-MI; lipidomics; Fourier transform infrared spectroscopy; heart failure; post-myocardial infarction ventricular remodeling; prognosis; myocardial necrosis biomarkers; neurohormonal activation biomarkers; inflammatory reaction biomarkers; fibrosis biomarkers; apoptosis biomarkers; new generation biomarkers; heart failure with preserved ejection fraction; heart failure with mid-range ejection fraction; heart failure with reduced ejection fraction; sirtuins; Sirt1; extracorporeal life support; mechanical circulatory support; ECMO; VAD; galectin-3; sST2; heart failure; liquid biopsy; tissue biopsy; EMBs; cardiac rejection monitoring; biomarkers; heart transplant; microRNA; mRNA; gene expression profiling; exosomes; unstable angina; Nourin; miRNAs; inflammatory diagnostic biomarkers; reversible myocardial ischemia; acute coronary syndromes